PARP regulates TGF-β receptor type II expression in estrogen receptor-positive breast cancer cell lines

被引:0
|
作者
Sterling, Julie A. [1 ]
Wu, Liang [1 ]
Banerji, Sunandita S. [1 ]
机构
[1] Med Univ Ohio, Dept Biochem & Canc Biol, Toledo, OH 43614 USA
关键词
TGF-beta receptor type II; estrogen receptor-positive; breast cancer; PARP; CCAAT box;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Expression of the tumor suppressor gene, transforming growth factor beta receptor type II (T beta RII) is often reduced in estrogen receptor-positive breast cancer cells leading to uninhibited tumor cell growth. A clear understanding of its regulation is necessary to identify potential mechanisms to re-express this tumor suppressor gene. Materials and Methods: The regulation of T beta RII expression was studied by utilizing 5' promoter deletion constructs, followed by EMSA analyses. The resulting binding protein was affinity purified and identified by mass spectrophotometry. Results: An inverted CCAAT box centered at -79 was found to be essential for T beta RII promoter activity. Purification of the protein binding to this region and subsequent mass spectrophotometric analysis identified the binding protein as poly(ADP-ribose)polyinerase I (PARP). ChIP assays verified that PARP interacted with the TPRII promoter in vivo. Conclusion: The present study demonstrated that PARP is important for T beta RII expression in estrogen receptor-positive breast cancer cell lines.
引用
收藏
页码:1893 / 1901
页数:9
相关论文
共 50 条
  • [41] MICROTUBULE DISRUPTION INDUCED BY ESTRADIOL IN ESTROGEN RECEPTOR-POSITIVE AND RECEPTOR-NEGATIVE HUMAN BREAST-CANCER CELL-LINES
    AIZUYOKOTA, E
    ICHINOSEKI, K
    SATO, Y
    CARCINOGENESIS, 1994, 15 (09) : 1875 - 1879
  • [42] The Intestinal Microbiome and Estrogen Receptor-Positive Female Breast Cancer
    Kwa, Maryann
    Plottel, Claudia S.
    Blaser, Martin J.
    Adams, Sylvia
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2016, 108 (08):
  • [43] Late Recurrences After Estrogen Receptor-Positive Breast Cancer
    Narod, Steven A.
    Giannakeas, Vasily
    Sopik, Victoria
    JAMA ONCOLOGY, 2020, 6 (02) : 301 - +
  • [44] Leptin as a Potential Target for Estrogen Receptor-Positive Breast Cancer
    Yom, Cha Kyong
    Lee, Kyung-Min
    Han, Wonshik
    Kim, Sung-Won
    Kim, Hee Sung
    Moon, Byung In
    Jeong, Ku-Young
    Im, Seock-Ah
    Noh, Dong-Young
    JOURNAL OF BREAST CANCER, 2013, 16 (02) : 138 - 145
  • [45] Reassessment of Estrogen Receptor Expression in Human Breast Cancer Cell Lines
    Ford, Christopher H. J.
    Al-Bader, Mate
    Al-Ayadhi, Bushra
    Francis, Issam
    ANTICANCER RESEARCH, 2011, 31 (02) : 521 - 527
  • [46] TOP2A RNA expression and recurrence in estrogen receptor-positive breast cancer
    Joseph A. Sparano
    Lori J. Goldstein
    Nancy E. Davidson
    George W. Sledge
    Robert Gray
    Breast Cancer Research and Treatment, 2012, 134 : 751 - 757
  • [47] TOP2A RNA expression and recurrence in estrogen receptor-positive breast cancer
    Sparano, Joseph A.
    Goldstein, Lori J.
    Davidson, Nancy E.
    Sledge, George W., Jr.
    Gray, Robert
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 134 (02) : 751 - 757
  • [48] Gene expression associated with endocrine therapy resistance in estrogen receptor-positive breast cancer
    Jones, Veronica
    Yin, Hongwei Holly
    Yuan, Yate-Ching
    Wang, Yongzhe
    Li, Sierra Min
    Aljaber, Dana
    Sanchez, Angelica
    Quinones, Christine
    Schmolze, Dan
    Yuan, Yuan
    Mortimer, Joanne
    Yee, Lisa
    Kruper, Laura
    Jovanovic-Talisman, Tijana
    Tomsic, Jerneja
    Sanchez, Nancy
    Chavez, Tanya
    O'Regan, Ruth M.
    Khan, Qamar J.
    Davis, Melissa
    Kalinsky, Kevin
    Meisel, Jane
    Kittles, Rick
    Rodriguez-Rodriguez, Lorna
    Seewaldt, Victoria
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [49] Major Impact of Sampling Methodology on Gene Expression in Estrogen Receptor-Positive Breast Cancer
    Gao, Qiong
    Lopez-Knowles, Elena
    Cheang, Maggie Chon U.
    Morden, James
    Ribas, Ricardo
    Sidhu, Kally
    Evans, David
    Martins, Vera
    Dodson, Andrew
    Skene, Anthony
    Holcombe, Chris
    Mallon, Elizabeth
    Evans, Abigail
    Bliss, Judith M.
    Robertson, John
    Smith, Ian
    Martin, Lesley-Ann
    Dowsett, Mitch
    JNCI CANCER SPECTRUM, 2018, 2 (02)
  • [50] Bicalutamide Plus Aromatase Inhibitor in Patients with Estrogen Receptor-Positive/Androgen Receptor-Positive Advanced Breast Cancer
    Lu, Qianyi
    Xia, Wen
    Lee, Kaping
    Zhang, Jingmin
    Yuan, Huimin
    Yuan, Zhongyu
    Shi, Yanxia
    Wang, Shusen
    Xu, Fei
    ONCOLOGIST, 2020, 25 (01): : 21 - +